Showing results (71-80 of 1,072) with videos related to
Sort By:
Pageof 108
Interventional Cardiology Clinics|June 6, 2017
Basics of Antithrombotic Therapy for Cardiovascular Disease: Pharmacologic Targets of Platelet Inhibitors and AnticoagulantsPiera Capranzano, Dominick J AngiolilloFrontiers in Cardiovascular Medicine|September 12, 2022
De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?Mattia Galli, Dominick J AngiolilloItalian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|December 11, 2003
[Past, present, and future of intracoronary brachytherapy]Dominick J Angiolillo, Manel SabatéAmerican Heart Journal|July 31, 2008
Pharmacology of emerging novel platelet inhibitorsDominick J Angiolillo, Piera CapranzanoAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 27, 2010
Platelet P2Y₁₂ receptor inhibition: an update on clinical drug developmentDavid Vivas, Dominick J AngiolilloBest Practice & Research. Clinical Endocrinology & Metabolism|June 13, 2009
Aspirin and clopidogrel: efficacy and resistance in diabetes mellitusDominick J Angiolillo, Siva SuryadevaraNature Reviews. Cardiology|October 8, 2014
Novel antiplatelet agents in acute coronary syndromeFrancesco Franchi, Dominick J AngiolilloCatheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2012
Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus statusPiera Capranzano, Jose Luis Ferreiro, Masafumi Ueno, et al.European Heart Journal. Cardiovascular Pharmacotherapy|July 25, 2024
P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysisMattia Galli, Claudio Laudani, Giovanni Occhipinti, et al.European Heart Journal|November 10, 2025
Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?Mattia Galli, Jurrien Ten Berg, Marco Valgimigli, et al.Pageof 108